317 related articles for article (PubMed ID: 15596830)
21. Native molecular state of adeno-associated viral vectors revealed by single-molecule sequencing.
Kapranov P; Chen L; Dederich D; Dong B; He J; Steinmann KE; Moore AR; Thompson JF; Milos PM; Xiao W
Hum Gene Ther; 2012 Jan; 23(1):46-55. PubMed ID: 21875357
[TBL] [Abstract][Full Text] [Related]
22. Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency.
Xu Z; Yue Y; Lai Y; Ye C; Qiu J; Pintel DJ; Duan D
Hum Gene Ther; 2004 Sep; 15(9):896-905. PubMed ID: 15353044
[TBL] [Abstract][Full Text] [Related]
23. Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype.
Grimm D; Pandey K; Nakai H; Storm TA; Kay MA
J Virol; 2006 Jan; 80(1):426-39. PubMed ID: 16352567
[TBL] [Abstract][Full Text] [Related]
24. Efficient transgene reconstitution with hybrid dual AAV vectors carrying the minimized bridging sequences.
Ghosh A; Yue Y; Duan D
Hum Gene Ther; 2011 Jan; 22(1):77-83. PubMed ID: 20662564
[TBL] [Abstract][Full Text] [Related]
25. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
26. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome.
Giraud C; Winocour E; Berns KI
J Virol; 1995 Nov; 69(11):6917-24. PubMed ID: 7474109
[TBL] [Abstract][Full Text] [Related]
27. Construction and gene expression analysis of a single-stranded DNA minivector based on an inverted terminal repeat of adeno-associated virus.
Ping H; Liu X; Zhu D; Li T; Zhang C
Mol Biotechnol; 2015 Apr; 57(4):382-90. PubMed ID: 25555376
[TBL] [Abstract][Full Text] [Related]
28. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
[TBL] [Abstract][Full Text] [Related]
29. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
[TBL] [Abstract][Full Text] [Related]
30. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.
Rabinowitz JE; Rolling F; Li C; Conrath H; Xiao W; Xiao X; Samulski RJ
J Virol; 2002 Jan; 76(2):791-801. PubMed ID: 11752169
[TBL] [Abstract][Full Text] [Related]
31. AAV recombineering with single strand oligonucleotides.
Hirsch ML; Storici F; Li C; Choi VW; Samulski RJ
PLoS One; 2009 Nov; 4(11):e7705. PubMed ID: 19888330
[TBL] [Abstract][Full Text] [Related]
32. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue.
Duan D; Sharma P; Yang J; Yue Y; Dudus L; Zhang Y; Fisher KJ; Engelhardt JF
J Virol; 1998 Nov; 72(11):8568-77. PubMed ID: 9765395
[TBL] [Abstract][Full Text] [Related]
33. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
34. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison.
Duan D; Yue Y; Engelhardt JF
Mol Ther; 2001 Oct; 4(4):383-91. PubMed ID: 11592843
[TBL] [Abstract][Full Text] [Related]
35. Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.
Wang XS; Khuntirat B; Qing K; Ponnazhagan S; Kube DM; Zhou S; Dwarki VJ; Srivastava A
J Virol; 1998 Jul; 72(7):5472-80. PubMed ID: 9621003
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
Dong JY; Fan PD; Frizzell RA
Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224
[TBL] [Abstract][Full Text] [Related]
37. Double strand interaction is the predominant pathway for intermolecular recombination of adeno-associated viral genomes.
Yue Y; Duan D
Virology; 2003 Aug; 313(1):1-7. PubMed ID: 12951015
[TBL] [Abstract][Full Text] [Related]
38. A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle.
Xiao X; Xiao W; Li J; Samulski RJ
J Virol; 1997 Feb; 71(2):941-8. PubMed ID: 8995611
[TBL] [Abstract][Full Text] [Related]
39. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro.
Yang CC; Xiao X; Zhu X; Ansardi DC; Epstein ND; Frey MR; Matera AG; Samulski RJ
J Virol; 1997 Dec; 71(12):9231-47. PubMed ID: 9371582
[TBL] [Abstract][Full Text] [Related]
40. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
